fashion -WSS

fashion

author：entertainment 2025-09-27 23:33:45 - browse：537

Christine Kao/STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies.

PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves. So when new market developments threaten to diminish or wipe away that revenue stream, PBMs find crafty ways to keep as much of those dollars as possible — often at the expense of employers.

One such case occurred last year, when a wave of Humira biosimilars entered the market and drug companies slashed the list prices of their insulin products. CVS Caremark, the PBM owned by CVS Health that oversees the prescription drug benefits of 103 million people, told its employer clients that it anticipated “more lower-cost products (including specialty biosimilars) may become preferred products” on its lists of approved drugs for 2024, according to documents obtained by STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Amylyx ALS drug fails large clinical trial

WSS

IVF, abortion rights issues kick off Biden’s State of the Union

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

RSV shot was 90% effective at preventing hospitalizations in kids

UnitedHealth quietly bought dozens of outpatient centers

Eyeing GLP

The problem with charging patients to message their doctors

hotspot

fashion

focus

Cancer drug shortages should be causing more outrage

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Guidelines to prevent youth baseball injuries need more muscle

FDA poised to publish guidelines for clinical trial diversity

The cancer drug shortage isn’t new — and neither are the solutions

H5N1 virus can be tracked in retail milk, scientists say

Heart attack and stroke risk calculators need revising

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Change Healthcare payments predicted restored March 15

entertainment

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Sen. Paul opposes bill to ban Chinese biotechs

Liver decline slowed by off

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Bird flu surveillance in wastewater gets boost from consortium

A deep dive into Applied Therapeutics’ data, and questions on Cassava

hotspot

explore

Wikipedia

leisure time